Order Article Reprints

Labé C, Chehadeh A, Winter A, Pracht S, Stuebner KM, Lewellen M, Eskander B, O’Sullivan MG, Tabaran A-F, Ober C, et al. Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care. Veterinary Sciences. 2025; 12(10):921. https://doi.org/10.3390/vetsci12100921

Labé, Courtney, Andrea Chehadeh, Amber Winter, Sara Pracht, Kathy M. Stuebner, Mitzi Lewellen, Bishoy Eskander, M. Gerard O’Sullivan, Alexandru-Flaviu Tabaran, Christopher Ober, and et al. 2025. "Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care" Veterinary Sciences 12, no. 10: 921. https://doi.org/10.3390/vetsci12100921

Labé, C., Chehadeh, A., Winter, A., Pracht, S., Stuebner, K. M., Lewellen, M., Eskander, B., O’Sullivan, M. G., Tabaran, A.-F., Ober, C., Henson, M. S., Seelig, D., Russell, S. J., Modiano, J. F., Naik, S., & Makielski, K. M. (2025). Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care. Veterinary Sciences, 12(10), 921. https://doi.org/10.3390/vetsci12100921